SAM.gov · Award Notice

Advance the development of SCY-247, a novel antifungal currently in Phase 1 clinical trials, for the treatment of invasive candidiasis and prophylaxis of invasive fungal disease as oral and IC formula

• Verified from source 3 days ago
• Updated 3 days ago

Agency

HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Office

OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE | BARDA - ASPR / DAAPPO / BARDA DCMA

Type

Award Notice

Kind

contract

Posted

Sep 25, 2026

Place

Jersey City, NJ

Notice ID

5d2b1c5f6d094d72ad9916f20fc33ed3

Source

SAM.gov

First seen

Sep 26, 2026, 2:42 PM UTC

Contacts

• Audrey Glover

  [email protected]

• Veronica Stroud

  [email protected]

Related links

• SAM.gov notice

Full record synced 3 days ago from SAM.gov (data extract)